Becker's Healthcare May 12, 2022
Andrew Cass

Medicare Part D spending on top brand-name drugs over a five-year period “more than made up the money” that drugmakers say it costs to develop new medications, according to a May 11 AARP report.

AARP’s Public Policy Institute researched Medicare spending between between 2016 and 2020 on the 10 brand-name drugs the program spent the most on in 2020, according to the report.

The institute’s research found that, on average, Medicare Part D spending was more than five times higher than the average costs to develop a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Medicare, Patient / Consumer, Provider, Survey / Study, Trends
HHS Announces Medicaid and Medicare Flexibilities, Investigations post-Change Healthcare Cyberattack
Medicare, Medicaid made $100B in improper payments in 2023
Medicare’s GLP-1 spending is skyrocketing, even without weight loss coverage: KFF
Can Hospital At Home Finally Hit Its Tipping Point? Lessons From The Hospitalist Field
Is Medicare keeping pace with our aging population? Experts say 'we need to double down and go faster'

Share This Article